Teradata has been named one of only 11 vendors in the 2025 Gartner Peer Insights™ Voice of the Customer for Data Science and Machine Learning Platforms report, based on feedback from 21 verified end-user reviews collected through August 2025. The company earned a 95% Willingness to Recommend score, reflecting strong customer advocacy, and achieved a 4.7 out of 5 rating for Product Capabilities, underlining the platform’s depth, reliability and functionality across the data science life cycle. This recognition underscores Teradata’s position in delivering scalable AI/ML development tools that support everything from data preparation to model deployment and monitoring.

In the past year, Teradata executed more than 150 enterprise AI engagements spanning financial services, healthcare, manufacturing and defense. Key use cases included fraud-detection model deployments for a multinational bank, which reduced model rollout times by over 40%, and analysis of more than 50,000 weekly customer interaction transcripts for an Asian banking client using vectorized language models to identify net promoter score drivers. In manufacturing, integration of IoT telemetry with design documentation cut R&D cycle times by 25%, while a European defense agency leveraged AI-assisted pattern analysis to enhance camouflage effectiveness in real time. In healthcare, an in-database imaging pipeline processed mammogram datasets at up to 10 TB per hour while maintaining strict patient confidentiality.

A MarketBeat survey of fourteen brokerages yields a consensus rating of Hold for Teradata shares. Among these, one analyst recommends Sell, eight recommend Hold, four recommend Buy and one recommends Strong Buy. Over the past year, analysts have set mid-range twelve-month targets near $29.44. Notable recent revisions include Morgan Stanley’s upgrade to Overweight with a target lifted to $35.00 and Evercore ISI’s upgrade to Outperform with a target of $28.00. Institutional investors hold approximately 90% of the company’s outstanding shares, with AQR Capital Management increasing its stake by 175% in Q2 and Boston Partners adding nearly 785,000 shares in Q3.